Faeth Therapeutics, Inc. Earnings Per Share (Basic)
Faeth Therapeutics, Inc. (FTH) reported Earnings Per Share (Basic) of -$2.84 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- Faeth Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$2.84.
- Faeth Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$131.45.
- Faeth Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$3.74.
- Faeth Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$3.62.
- Faeth Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$16.72.
- Faeth Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$24.01.
- Faeth Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.22.
- Faeth Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.58.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.84 10-Q · filed 2026-08-04 | -$53.50 10-Q · filed 2026-08-04 | -$69.87 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$82.67 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2026-03-31 | -$131.45 10-Q · filed 2026-05-15 | -$136.87 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$141.07 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$145.28 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-12-31 | -$3.74 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$7.36 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$11.28 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$16.72 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$3.62 10-Q · filed 2025-11-14 | -$7.54 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$12.98 10-Q · filed 2025-11-14 | -$19.16 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-06-30 | -$3.91 10-Q · filed 2026-08-04 | -$9.36 10-Q · filed 2026-08-04 | -$15.54 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$21.31 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-03-31 | -$5.45 10-Q · filed 2026-05-15 | -$0.27 10-Q · filed 2025-05-06 | -$11.62 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$17.39 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$23.08 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||
| 2024-12-31 | -$6.18 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$11.94 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$17.63 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$24.01 10-K · filed 2026-03-30 | -$1.20 10-K · filed 2025-03-28 | |||
| 2024-09-30 | -$5.77 10-Q · filed 2025-11-14 | -$0.29 10-Q · filed 2024-11-14 | -$11.46 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$17.84 10-Q · filed 2025-11-14 | -$0.89 10-Q · filed 2024-11-14 | -$2.27 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | -$5.69 10-Q · filed 2025-08-05 | -$0.28 10-Q · filed 2024-08-06 | -$12.07 10-Q · filed 2025-08-05 | -$0.60 10-Q · filed 2024-08-06 | -$1.32 derived: net income ÷ weighted average shares · filed 2025-08-05 | -$1.55 derived: net income ÷ weighted average shares · filed 2025-08-05 | ||
| 2024-03-31 | -$0.32 10-Q · filed 2025-05-06 | -$0.62 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.20 derived: net income ÷ weighted average shares · filed 2025-05-06 | ||||
| 2023-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.58 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$1.22 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | -$0.28 10-Q · filed 2024-11-14 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.92 10-Q · filed 2024-11-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-06 | -$0.64 10-Q · filed 2024-08-06 | -$1.04 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$1.47 derived: net income ÷ weighted average shares · filed 2024-08-06 | ||||
| 2023-03-31 | -$0.33 10-Q · filed 2024-05-09 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-05-09 | ||||
| 2022-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.83 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.58 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$0.44 10-Q · filed 2023-11-07 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.18 10-Q · filed 2023-11-07 | -$1.49 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.34 10-Q · filed 2023-08-03 | -$0.75 10-Q · filed 2023-08-03 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-08-03 | ||||
| 2022-03-31 | -$0.40 10-Q · filed 2023-05-09 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-05-09 | |||||
| 2021-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$1.33 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | -$0.32 10-Q · filed 2022-11-08 | -$1.03 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |